|
 |
CravitThis page contains recent news articles, when available, and an overview of Cravit but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.The second half of the evening sprang to life with the witty situation comedy Our Wedding Table by Toronto playwright Isaac Cravit. ... View Magazine Kenapa Bisa Kena Penyakit Lichen Planus? - Jan 3, 2010 Untuk saat ini saya mengkonsumsi obat Cravit Levofloxacin 500 mg (antibiotik), Sulcolon Sulfasalazine 500 mg,Galflux Domperidone 10 mg, ... Detikcom Daiichi Sankyo Submits Application for Approval of Levofloxacin Hydrate ... - 14 Nov 2009 Cravit®, an oral Levofloxacin Hydrate agent, already is a widely accepted treatment in formulations of 500mg and 250mg tablets and as a 10% fine granular ... Ethio Planet News 다ì?´ì?´ì°Œ ì‚°êµ?, ë ˆë³´í”„ë¡?ì‚¬ì‹ ì£¼ì‚¬ìš© 허가 ì‹ ì² - Oct 30, 2009 ...회사측ì—? 따르면 경구용 ë ˆë³´í”„ë¡?ì‚¬ì‹ í•ìƒ?ì œ, í?¬ë?¼ë¹„트(Cravit)는 ì?´ë¯¸ 500mgê³¼ 250mg ì •ì œ ë°? 10% 미세 ê³¼ë¦½ì œë¡œ ì‹œíŒ?ë?˜ê³ 있으며 추가로 ì£¼ì‚¬ì œë¥¼ ë?„입함으로 ê°?ì—¼ ... 메디포뉴스 CARP defends itself against critics - Aug 1, 2007 She referred me to David Cravit, senior vice-president of marketing of 50Plus.com. ... The relationship of 50Plus. com and CARP is "clear," Cravit says. ... Financial Post Phone pushes right buttons - Nov 4, 2006 Even though most boomers don't yet need grab bars in the bathtub or a simplified cellphone, Cravit says the estimated five million Canadians caring for a ... Canada.com No such thing as 'typical senior' - Feb 28, 2007 David Cravit, vice-president of marketing for the 50-Plus Group, says the one thing this report stresses is that there's no such thing as a "typical senior. ... Pay-Per-View - The Record - ProQuest Archiver DAIICHI PHARMA'S FY04 PRETAX PROFIT SEEN RISING 18%. - Mar 24, 2005 Strong domestic sales of the synthetic antibacterial agent Cravit and ... Growth in exports of raw materials for Cravit to the US will also boost sales. ... Free with registration - AsiaPulse News - AccessMyLibrary.com Daiichi Sankyo to Invest in Kearney Venture Partners, LP - Sep 8, 2006 ...and the synthetic antibacterial agent Cravit(R) (levofloxacin). Both companies specialize in the field of cardiovascular disease and have used their ... Free with registration - PR Newswire - AccessMyLibrary.com Japan stock market week to May 15, 2006.(pharmaceutical industry … - May 22, 2006 Revenues from the mainstay Cravit (levofloxacin), a prescription ophthalmic solution for the treatment of bacterial conjunctivitis, rose 3.1% to 13.0 ... $4.95 - Pharma Marketletter - ECNext Japan Drug Makers Sales Are Solid - Nov 7, 2007 ...yen from 78.35 billion yen, thanks to cost cutting and growing sales of Daiichi Sankyo's blood-pressure drug Benicar and antibacterial agent Cravit. ... Subscription - Wall Street Journal Online - Dow Jones & Company Making user-friendly software an easy sell - Dec 15, 2008 Mr. Cravit says that he's not disputing there is a viable market for SoftShell ... As far as marketing channels go, Mr. Cravit had this advice: "They can ... Globe and Mail More older Canadians stuck in the workplace - Aug 25, 2007 Others may work to finance luxuries their pensions don't cover, Cravit says, citing his favourite example of a Calgary man in his 80s who works part-time at ... Canada.com Aging population poses spectre of worker shortages; Experienced … - Jul 18, 2007 It's a very real problem," [David Cravit] said. "We're travelling, going back to university, there's all this stuff I can do. I'm in better shape than ever ... Pay-Per-View - The Record - ProQuest Archiver Japan stock market week to Jan 23. - Jan 30, 2006 Daiichi-Sankyo rose 1.5% after it announced that both of Sankyo and Daiichi will begin a marketing collaboration in April for the antibacterial agent Cravit ... $4.95 - Pharma Marketletter - ECNext <P>This article has been removed and is no longer available.</P> | … - Mar 24, 2005 Article: Online Direct announces appointment of David Cravit as ... ... David Cravit as President and Chief Executive Officer, replacing Andrew ... a ... Pay-Per-View - Canadian Corporate News - HighBeam Research Boomers to work longer than expected - Jul 17, 2007 It's a very real problem," Cravit said. "We're travelling, going back to university, there's all this stuff I can do. I'm in better shape than ever before. ... Toronto Star Fringe's siren, queen and dame - Jul 11, 2006 Still, writer/director Isaac Cravit has conjured an interesting tale, ... And while the play goes in some unexpected directions, Cravit needs to ditch the ... Pay-Per-View - Toronto Star - ProQuest Archiver Uncertainty for boomers in golden years - Jul 18, 2007 Part of the problem is that boomers are living longer and have to budget for their increased life expectancy, said David Cravit, vice-president of marketing ... Toronto Star Fifty-Plus Announces Loan Financing and Management Changes - Nov 14, 2005 Mr. Vengroff will be joined by David Cravit, former President and COO of the Sonar ... Both Cravit and Shaw bring an extensive amount of online marketing ... ccnmatthews.com Japan stock market week to May 2.(pharmaceutical index) - May 2, 2005 Revenues from Cravit in Japan edged down 0.6% to 47.1 billion yen due to a price cut but the drug's volume sales grew and exceeded projections. $4.95 - Pharma Marketletter - ECNext Strong 1st quarter for Japan's Santen.(Brief Article) - Aug 29, 2005 Japanese sales of Santen's mainstay drug Cravit (levofloxacin), for the treatment of bacterial conjunctivitis, rose 4.5% year-on-year to 3.5 billion yen, ... $4.95 - Pharma Marketletter - ECNext Japan stock market week to June 12, 2006. - Jun 19, 2006 Cravit has been used in Japan at a dose of two 100mg tablets two or three times a day for serious conditions. The 500mg tablet for once-daily administration ... $9.94 - Pharma Marketletter - Alacra Store Japan's Daiichi raises full-year forecast despite dip in nine-month... - Feb 14, 2005 Daiichi notes that Japanese revenue from the antibacterial drug Cravit ... However, the firm notes that volume sales of Cravit have been increasing ... $4.95 - Pharma Marketletter - ECNext Fifty-Plus.Net International Inc. - Dec 3, 2007 Eric L. Vengroff and David J. Cravit will be appointed as Executive Vice Presidents, and Gordon A. Poland will be appointed as Chief Financial Officer. ... marketwire.com Daiichi FY2005 net income soars 39%.(pharmaceutical industry) - May 16, 2005 Revenues from Cravit in Japan edged down 0.6% to 47.1 billion yen due to the price cut but the drug's volume grew and exceeded target. ... $4.95 - Pharma Marketletter - ECNext Fifty-Plus.Net International Inc. Announces Proposed Acquisition of... - Aug 30, 2007 Eric Vengroff and David Cravit will be appointed as Executive Vice Presidents, and Gordon Poland will be appointed as Chief Financial Officer. ... marketwire.com Japan stock market week to March 28. - Apr 4, 2005 High-profit-margin Cravit is expected to contribute to an improvement in gross profit margin. R&D expenses are forecast to be below the target of 59.6 ... $4.95 - Pharma Marketletter - ECNext Interim 2008 DAIICHI SANKYO CO LTD Earnings Presentation Webcast ( … - Nov 7, 2007 Cravit is on an upward trend, despite the decrease in the antibiotic market. ... Sankyo and Daiichi co-promoted Olmetec and Cravit before their full ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com Profile: Colleen DeCourcy - Jun 16, 2008 Career: Her first job was as a receptionist at Toronto retail agency Saffer Cravit & Freedman. After working as director of creative strategy at ICE ... Adweek What (and what not) to eat to prevent cancer - Sep 2, 2008 As can be gleaned from an article written by Cynthia Ross Cravit for Yahoo! Canada Lifestyle (with data from World Cancer Research Fund, American Institute ... Philippine Star Students dive into election debate; Questions 'dazzle' candidates... - Jan 17, 2006 Grade 12 student Rachel Cravit, 18, asked incumbent Joe Volpe why the Liberal party's campaign is focused on values. "You invest in making sure everyone has ... Pay-Per-View - Toronto Star - ProQuest Archiver 13 examples show how system works - Sep 23, 2005 ...appointment of Louis Brandeis, Harry Truman (Harold Burton), Dwight Eisenhower (William Brennan) and Richard Nixon (Lewis Powell). David Cravit, Toronto. Pay-Per-View - Toronto Star - ProQuest Archiver Elder Pharmaceuticals Ltd acquires Elder Universal Pharm(Nepal) from ... - Oct 3, 2008 Johnson & Johnson (US); Cravit: Daiichi Pharmaceutical, Je Il Pharm (Pacific Rim); Tavanic: Sanofi-Aventis…total business solution to the pharmaceutical and ... Pay-Per-View - deals - Alacra Store He's not young, he's my doctor - Aug 4, 2007 David Cravit, senior vice-president of marketing at 50-plus, Canada's largest Internet portal for boomers, says his audience likes to be treated by young ... Toronto Star The Antibacterial Drug Market Analysis 2008-2013 - Mar 19, 2008 Cravit Will Gradually Decline in Sales. 6.1. Penicillins Will Retain Their Niche Despite a. Marked Decline in Sales. 6.2. Can GSK's Augmentin Overcome ... $4,356.00 - VISIONGAIN A - Alacra Store Device ups volume for boomers - Jun 16, 2007 ...says David Cravit, senior vice-president of marketing for Toronto-based 50Plus Group, the largest Internet portal for boomers and seniors in Canada. ... Canada.com MorphoSys and Japanese Pharmaceutical Group Daiichi Sankyo Form … - Mar 16, 2006 ...on the Japanese market, including the antihypertensive Benicar(R) (olmesartan medoxomil) and the synthetic antibacterial agent Cravit(R) (levofloxacin). ... RedOrbit Elder Pharmaceuticals Ltd acquires a minority stake in Elder Universal... - Oct 3, 2008 Johnson & Johnson (US); Cravit: Daiichi Pharmaceutical, Je Il Pharm (Pacific Rim); Tavanic: Sanofi-Aventis…total business solution to the pharmaceutical and ... Pay-Per-View - deals - Alacra Store KAI Pharmaceuticals, Inc. and Sankyo Company, Limited Enter Global … - Jan 9, 2006 ...on the Japanese market, including the antihypertensive Benicar(R) (olmesartan medoxomil) and the synthetic antibacterial agent Cravit(R) (levofloxacin). ... biotech-intelligence.com 第一制è?¯ä¸Žä¸‰å…±çš„å?ˆå¹¶å‰?景分æž? - Jul 4, 2005 ...但总体而言，日本第一制è?¯çš„产å“?线处于æˆ?熟期，其顶级畅销è?¯ç‰©å¦‚： 左氧氟沙星（levofloxacin，Cravit）ã€?噻氯匹啶（ticlopidine，Panaldine）由于é?žä¸“利 è?¯çš„竞争，未æ?¥ ... 新浪网 Press Release: Bayer/Schering-Plough/Shionogi's Avelox Has … - Apr 17, 2008 ...in overall clinical efficacy to the market leader levofloxacin -- Johnson & Johnson's Levaquin, Sanofi-Aventis's Tavanic and Daiichi Sankyo's Cravit. ... Pay-Per-View - PR Newswire - HighBeam Research YM Biosciences Licenses Monoclonal Antibody, Nimotuzumab, to Daiichi ... - Jul 31, 2006 ...(olmesartan medoxomil) and the synthetic antibacterial agent Cravit(R) (levofloxacin) and are strongly promoting drug information provision activities. ... Genetic Engineering News - Genetic Engineering News (press release) Daiichi Sankyo streamlining leads to fall in revenue but 24% increase... - May 26, 2008 Olmetec (olmesartan medoxomil), synthetic antibacterial agent Cravit (levofloxacin), Urief (silodosin) and the anti-inflammatory Loxonin (loxoprofen). ... $9.94 - Pharma Marketletter - Alacra Store Research and Markets: Daiichi Sankyo Pharmaceuticals is undertaking … - May 25, 2006 The future growth of the anti-infective Cravit is expected to be strong due to life-cycle management efforts. In fiscal 2005, sales of the antihypertensive, ... Genetic Engineering News - Genetic Engineering News (press release) Daiichi: sales up 0.2% at Yen 253.7 bn. - Feb 14, 2005 Artist (carvedilol), Hanp (carperitide), Cravit (levofloxacin), Panaldine (ticlopidine), and Omnipaque (iohexol), and a full-year forecast. Free with registration - Asia Africa Intelligence Wire - AccessMyLibrary.com Le Canada pourrait manquer d'employés en raison des départs à la … - Jul 17, 2007 ...a estimé David Cravit, vice-président marketing pour le Groupe 50 Plus, la division en ligne de l'Association canadienne des retraités. ... Matinternet FPN Announces Second Quarter Financial Results - Feb 28, 2006 We're seeing a steady stream of inquiries about our portfolio of Internet media," says David Cravit, Senior Vice President, Marketing. ... ccnmatthews.com Daiichi Sankyo: 8% half-year income rise.(Brief Article) - Dec 12, 2005 The firm's flagship antibacterial drug levofloxacin (sold as Cravit in Japan and Lavaquin in the USA) grew 13.5% to 23.6 billion yen, while bulk exports to ... Free with registration - Pharma Marketletter - AccessMyLibrary.com Daiichi Sankyo Announces the Release of Ultrasound Contrast Agent … - Jan 10, 2006 ...on the Japanese market, including the antihypertensive Benicar (olmesartan medoxomil) and the synthetic antibacterial agent Cravit (levofloxacin). ... japancorp.net Japan stock market week to Nov 14. - Nov 21, 2005 Daiichi recorded robust growth for its antibacterial drug levofloxacin (Cravit in Japan, Levaquin in the USA). Taisho was down 0.2%, after it reported a ... Free with registration - Pharma Marketletter - AccessMyLibrary.com Fifth Sankyo Takamine Memorial Award Announced. - Jul 13, 2007 ...on the Japanese market, including the antihypertensive Benicar (olmesartan medoxomil) and the synthetic antibacterial agent Cravit (levofloxacin). ... Free with registration - JCN Newswires - AccessMyLibrary.com Japan's pharma licks its wounds after NHI cuts.(National Health... - Mar 13, 2006 ...antibacterial agent Cravit (levflox-acin) and antihypertensitive drug Olmetec (olmesartan medoxomil), at 9.7%, 8.1% and 8.8%, respectively. ... Free with registration - Pharma Marketletter - AccessMyLibrary.com Fifty-Plus.Net International Inc. Announces Acquisition of Media and ... - Dec 31, 2007 Eric Vengroff and David Cravit were appointed as Executive Vice Presidents and Gordon Poland was appointed as Chief Financial Officer. ... Web Services Journal - Web Services Journal Continued Economic Burden Of Acute Coronary Syndrome Despite … - Apr 10, 2006 ...on the Japanese market, including the antihypertensive Benicar® (olmesartan medoxomil) and the synthetic antibacterial agent Cravit® (levofloxacin). ... Medical News Today - Medical News Today (press release) Daiichi Sankyo Announces Completion of Phase I Trial on the Anti- … - Apr 19, 2007 ...on the Japanese market, including the antihypertensive Benicar (olmesartan medoxomil) and the synthetic antibacterial agent Cravit (levofloxacin). ... Genetic Engineering News - Genetic Engineering News (press release) Your next big thing: Growth market - The retirement-ready - Dec 1, 2007 ...“They want new products and services to enable them to live more comfortably at home,â€? says David Cravit, senior vice-president of marketing at The 50Plus ... CanadianBusiness.com Daiichi Sankyo Pharmaceuticals is undertaking life-cycle management... - May 24, 2006 The future growth of the anti-infective Cravit is expected to be strong due to life-cycle management efforts. In fiscal 2005, sales of the antihypertensive, ... Free with registration - M2 Presswire - AccessMyLibrary.com Canada's 50-plus Generation is Changing Housing Demand - Nov 16, 2006 ..."This is a demographic that treats death as if it's a curable disease," said David Cravit, a senior vice-president with the 50Plus Group, ... realtytimes.com Fifty-Plus.net International Inc.: Introduction of New Dating Website - Jun 1, 2006 ...somewhat hesitant or uncomfortable posting their profiles on dating websites geared to a younger audience," said Executive Vice President David Cravit. ... ccnmatthews.com Media advisory/invitation: Press Conference at Queen's Park Launching... - Sep 18, 2007 ...director of external relations, CARP Antonia Codispoti, co-founder, OCCC Hilda Mackow, co-founder, OCCC David Cravit, senior vice president, ... newswire.ca Better-than-expected 1st qtr for Daiichi.(earnings)(Brief Article) - Aug 22, 2005 Among the company's major products, the antibacterial Cravit (levofloxacin) saw revenues grow 8% to 13.5 billion yen, with exports to US licensee Johnson ... $4.95 - Pharma Marketletter - ECNext Japan stock market week to August 8. - Aug 15, 2005 ...the fiscal year ending March 2006 (April-June 2005), led by growth of its mainstay antibacterial drug Cravit (levofloxacin) and other major compounds. ... $4.95 - Pharma Marketletter - ECNext Stock Commentary - Tokyo. - Aug 15, 2005 ...the fiscal year ending March 2006 (April-June 2005), led by growth of its mainstay antibacterial drug Cravit (levofloxacin) and other major compounds. ... $4.95 - Pharma Marketletter - ECNext Patent Expiries of Leading Antibiotics From Several Pharmaceutical … - Jan 9, 2007 The new Pharmacor report Emerging Antibacterial Agents finds that Johnson & Johnson's Levaquin, Sanofi-Aventis's Tavanic, Daiichi-Sankyo's Cravit, ... $4.95 - PR Newswire - ECNext Press Release: YM BIOSCIENCES INC. - Re Joint Venture. - PR … - Jul 31, 2006 ...(olmesartan medoxomil) and the synthetic antibacterial agent Cravit(R) (levofloxacin) and are strongly promoting drug information provision activities. ... Pay-Per-View - PR Newswire UK Disclose - HighBeam Research Press Release: YM Biosciences Licenses Monoclonal Antibody, … - Jul 31, 2006 ...(olmesartan medoxomil) and the synthetic antibacterial agent Cravit(R) (levofloxacin) and are strongly promoting drug information provision activities. ... Pay-Per-View - PR Newswire - HighBeam Research Japan stock market week to May 14, 2007. - May 21, 2007 Sales of Cravit (levofloxacin), an ophthalmic solution for the treatment of bacterial conjunctivitis, edged down 0.5% to 13.2 billion yen due to competition ... $9.94 - Pharma Marketletter - Alacra Store Daiichi Sankyo sees increase in 2005 income.(Brief Article) - Feb 20, 2006 ...which produced revenue of 18.9 billion yen from 6.9 billion yen in 2004; the company's antibacterial, Cravit (levofloxacin), which saw Japanese sales ... $4.95 - Pharma Marketletter - ECNext Japan stock market week to Feb 13, 2006. - Feb 20, 2006 Sales of the mainstay Cravit (levofloxacin), an ophthalmic treatment for bacterial conjunctivitis, increased 3.3% to 10.8 billion yen. ... $4.95 - Pharma Marketletter - ECNext Press Release: Daiichi Sankyo to Invest in Kearney Venture Partners,... - Sep 8, 2006 Olmetec(R) (olmesartan medoxomil), which is marketed in the U.S. as Benicar(R), and the synthetic antibacterial agent Cravit(R) (levofloxacin). ... Pay-Per-View - PR Newswire - HighBeam Research Japan stock market week to August 15.(pharmaceuticals) - Aug 22, 2005 Revenues in Japan of the mainstay drug Cravit (levofloxacin), for the treatment of bacterial conjunctivitis, rose 4.5% year-on-year to 3.5 billion yen. ... $4.95 - Pharma Marketletter - ECNext Patent expiry will "constrain" antibacterial market. - Jan 15, 2007 These include, Johnson & Johnson's Levaquin, Sanofi-Aventis' Tavanic and Daiichi Sankyo's Cravit (all levofloxacin); Merck & Co's Primaxin (imipenem); ... $4.95 - Pharma Marketletter - ECNext Patent expiry will "constrain" antibacterial market. - Jan 15, 2007 These include, Johnson & Johnson's Levaquin, Sanofi-Aventis' Tavanic and Daiichi Sankyo's Cravit (all levofloxacin); Merck & Co's Primaxin (imipenem); ... $9.94 - Pharma Marketletter - Alacra Store Japan stock market week to Nov 6, 2006. - Nov 13, 2006 Japanese sales of Cravit (levofloxacin) for the treatment of bacterial conjunctivitis increased 2.0% to 7.2 billion yen and turnover of Hyalein (pemirolast ... $9.94 - Pharma Marketletter - Alacra Store Daiichi Sankyo's first-half profit jumps 35.3%. - Nov 13, 2006 ...several of the group's leading products maintained high levels of sales, including the broad-spectrum oral antibacterial agent, Cravit (levofloxacin), ... $9.94 - Pharma Marketletter - Alacra Store Press Release: Patent Expiries of Leading Antibiotics From Several … - Jan 9, 2007 The new Pharmacor report Emerging Antibacterial Agents finds that Johnson & Johnson's Levaquin, Sanofi-Aventis's Tavanic, Daiichi-Sankyo's Cravit, ... Pay-Per-View - PR Newswire - HighBeam Research Kalbe, The Making of No. 1 Pharma - Jun 1, 2006 Dari subkategori produk antibiotik tercatat nama-nama Cefspan, Fixef, Cravit, Reskuin, Tarivid, Danofloc, Cefizox dan Cefazol. ... Swa Le titre de Sankyo Pharmaceutical a grimpé - Feb 21, 2005 ...de son chiffre d'affaires au cours de l'exercice clos en mars 2004, tandis que celles de l'antibiotique Cravit avaient assuré 21% des ventes de Daiichi. ... Le Journal de Québec ИзменениÑ? на рынке антибактериальных препаратов в ближайшие - Jan 12, 2007 Ðто Ñ?вÑ?зано Ñ? иÑ?течением Ñ?рока патента на Ñ€Ñ?д ЛС: (Levaquin, Tavanic, Primaxin, Cravit, Omnicef, Merrem, Zosyn), производимых компаниÑ?ми Johnson & Johnson, ... ФармацевтичеÑ?кий веÑ?тник |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |
